Symrise AG (LON:0G6T)

Revance Therapeutics Revenue

Symrise AG had revenue of 2.55B EUR in the half year ending June 30, 2025, with 5.80% growth. This brings the company's revenue in the last twelve months to 4.99B, up 2.15% year-over-year. In the year 2024, Symrise AG had annual revenue of 5.00B with 5.67% growth.

• Revenue (ttm): 4.99B EUR
• Revenue Growth: +2.15%
• P/S Ratio: 2.27
• Revenue / Employee: 384.91K EUR
• Employees: 12,956
• Market Cap: 9.68B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.00B	268.33M	5.67%
Dec 31, 2023	4.73B	111.71M	2.42%
Dec 31, 2022	4.62B	792.79M	20.72%
Dec 31, 2021	3.83B	305.24M	8.67%
Dec 31, 2020	3.52B	112.60M	3.30%